The Clinical Support Laboratory offers processing, tracking, and testing of a broad range of clinical samples. Support can begin at the early stages of clinical trial development to aid in developing a comprehensive strategy for sample collection, processing, and testing with a special emphasis on immunologic testing. The lab collaborates with partners to develop customized assays or transfer existing assay technology with assay validation, data analysis and interpretation of results. Processing specializes in PBMC isolation and controlled rate freezing, ELISA based biomarker testing, and multiplex biomarker analysis using the Meso Scale Discovery (MSD) and Luminex platforms, and a broad spectrum of bioassays to assess cellular responses to antigens and mitogens including ELISPOT, cytotoxicity assays (e.g., ADCC), and proliferation assays. CSL supports CCR, DCEG, and NIAID Investigators and is available to advise Investigators from other Institutes. CSL is operated by Leidos Biomedical Research Inc. on behalf of NCI as part of the Frederick National Laboratory.
Currently, CCR, NIAID, and DCEG receive support from the Clinical Support Laboratory. Project scope is defined in consultation with the customer and cost estimates based on actual time and materials are provided for investigator review/approval before any project is initiated. Support can be for research or enter at the early stages of clinical trial development to aid in developing a comprehensive strategy for sample collection, processing, biomarker testing, and cellular immunity assays.
To request services from this NCI core facility, you must submit your requisition through NAS.